Stem Cells International / 2017 / Article / Fig 4

Review Article

Skeletal Muscle Cell Induction from Pluripotent Stem Cells

Figure 4

Myogenic cells induced from myoblast-derived iPSCs for DMD therapy. DMD patient-derived fibroblasts or myoblasts will be reprogramed into iPSCs by reprogramming factors (Oct4, Sox3, Klf4, and cMyc). These fibroblast- and myoblast-derived iPSCs will be induced to myogenic cells via combinatory small molecules and factors such as GSK3βi, forskolin, ascorbic acid, BMPi, ALK5i, Dex, EGF, oncostatin, insulin, bFGF, IGF, HGF, and Wnt3a. These iPSC-derived myogenic cells will be used for autologous cell therapy. Myoblast-derived iPSCs maintain epigenetic myogenic memory.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.